“leukemia” Archives

in
Entry Author Date Location
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones 06/20/16 National
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
UW Health Surgeon’s Startup Expanding Software to Monitor Patients 05/27/16 Wisconsin
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Dairyvative, Catalyze, & EnsoData: This Week’s Wisconsin Watch List 12/07/15 Wisconsin
MiRagen Lands $41M for MicroRNA Drugs in Cancer, Fibrosis 11/10/15 Boulder/Denver
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
TX Roundup: Need, Experiment Engine, Bigcommerce, Bellicum, CS Disco 12/02/14 Texas
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
MD Anderson Leverages IBM Watson in Cancer-Fighting Efforts 04/24/14 Texas
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Sunesis Waits Out Suspenseful Final Year of Pivotal Leukemia Trial 07/02/13 San Francisco
FDA Approves Ariad Leukemia Drug Three Months Ahead of Schedule 12/14/12 Boston
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors 04/27/11 San Diego
Genzyme-Sanofi Deal Might Be Close, Report Says 02/01/11 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Page 1 of 2 next page »